Medicinefromwww.theguardian.com2 days agoNovo Nordisk shares slide after Ozempic pill fails in Alzheimer's trialsOral semaglutide failed to slow Alzheimer's progression in two large trials, prompting a sharp share price drop for Novo Nordisk.
Businessfrom24/7 Wall St.4 weeks agoAs Dow Hits Record, High-Yield Dogs of the Dow Still a BargainBuying the ten highest-yielding Dow stocks can offer contrarian, high-dividend opportunities, with bargains in pharmaceutical and defensive sectors poised for 4Q and 2026.